Skip to main content
Premium Trial:

Request an Annual Quote

Polyplus-transfection Lands $1.8M Financing

NEW YORK (GenomeWeb News) – Polyplus-transfection has raised €1.2 million ($1.8 million) through a new funding round from existing investors.

The Strasbourg, France-based firm said it plans to use the funding primarily for its RNAplus research program, which aims to generate new oligonucleotides that are capable of silencing the expression of a target gene through RNA interference without the need for a delivery reagent.

The investment came from the issue of convertible bonds and it was led by existing investor CIC-Vizille Capital Innovation, and the participation of Avenir Finance Gestion and CIC Finance-CIC Investissement Alsace.

Polyplus-transfection also plans to add a new CEO and business development manager for its operations in the US, which contributes 40 percent of the firm's sales.

It also expects that the financing will enable it to continue development of Zip Nucleic Acid oligonucleotides and to defend some of its intellectual property.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.